share_log

PURE Bioscience (OTCMKTS:PURE) Stock Price Passes Above 200 Day Moving Average of $0.15

Defense World ·  Mar 29, 2023 02:23

PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) shares crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.15 and traded as high as $0.16. PURE Bioscience shares last traded at $0.16, with a volume of 28,193 shares traded.

PURE Bioscience Stock Up 20.7 %

The firm's 50 day simple moving average is $0.13 and its 200-day simple moving average is $0.15. The company has a market capitalization of $17.81 million, a PE ratio of -4.00 and a beta of 0.21.

Get PURE Bioscience alerts:

Institutional Inflows and Outflows

An institutional investor recently bought a new position in PURE Bioscience stock. IFG Advisory LLC bought a new stake in PURE Bioscience, Inc. (OTCMKTS:PURE – Get Rating) in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 809,809 shares of the company's stock, valued at approximately $161,000. IFG Advisory LLC owned 0.92% of PURE Bioscience at the end of the most recent quarter. Institutional investors own 0.92% of the company's stock.

PURE Bioscience Company Profile

(Get Rating)

PURE Bioscience, Inc engages in the discovery, development, and commercialization of proprietary antimicrobial products for pathogen and hygienic control. It offers silver dihydrogen citrate-based disinfecting and sanitizing products. The company was founded by Michael L. Krall on August 24, 1992 and is headquartered in Rancho Cucamonga, CA.

Featured Articles

  • Get a free copy of the StockNews.com research report on PURE Bioscience (PURE)
  • After an Earnings Blowout, Is Ciena Stock a Buying Opportunity?
  • Here's Why Viking Therapeutics Rose Over 50% on Obesity Drug Data
  • Meta Breaks Out Of A Base, Looks Like A Growth Stock Again
  • The Bottom Is In For McCormick & Company
  • Walgreens Boots Alliance: Blue Chip, High-Yield Turnaround Story

Receive News & Ratings for PURE Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PURE Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment